New endoscopic breast reconstruction could change surgery for cancer patients

NCT ID NCT06817954

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study will compare two surgical approaches for breast cancer patients who need a mastectomy (breast removal) and immediate reconstruction. One group will have standard surgery, while the other will use a newer, endoscopic-assisted technique that may involve smaller incisions. Researchers will track 800 women over time to see which method leads to fewer cancer recurrences and complications.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
endoscopic-assisted mastectomy and immediate breast reconstruction (procedure)
What this could lead to
If successful, this could show that endoscopic-assisted surgery is a safe and effective option for breast reconstruction after mastectomy, potentially reducing scarring and recovery time.
What could go wrong
This is an early-stage exploratory study, so results may not confirm superiority over standard surgery. Risks include complications like infection, bleeding, or recurrence, and the technique may not suit all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • The First Affiliated Hospital with Nanjing Medical University

    RECRUITING

    Nanjing, Jiangsu, 210009, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.